about
Immunological effects of vaccines combined with granulocyte colony-stimulating factor on a murine WEHI-3 leukemia model.A new peptide vaccine OCV-501: in vitro pharmacology and phase 1 study in patients with acute myeloid leukemiaInterleukin-15 enhances the proliferation, stimulatory phenotype, and antitumor effector functions of human gamma delta T cellsCD64-directed microtubule associated protein tau kills leukemic blasts ex vivo.Antigen-specific immunotherapy for acute myeloid leukemia: where are we now, and where do we go from here?KCa 3.1-a microglial target ready for drug repurposing?Bone marrow T-cell percentage: A novel prognostic indicator in acute myeloid leukemia.Effective control of acute myeloid leukaemia and acute lymphoblastic leukaemia progression by telomerase specific adoptive T-cell therapy.
P2860
Q33597774-9D800692-9FA6-4C79-A516-A46397C87655Q33849643-05574819-109D-4173-86D3-9A8DF8704FFEQ37294760-26ECD709-5A81-44D8-A690-1F75D19C91B2Q37687139-85FDEB97-EDE3-4500-BE81-9CA167FFBB6BQ38700209-9F89FB4E-892A-487F-B861-4E7EC45448F1Q38819263-0327421C-F320-4428-A4CD-CC73F3AF63CCQ40445337-86F9DCD2-1A4B-4CB6-A28A-2279BA3DF005Q49897464-87E903C4-943E-44C0-A084-2CA1FC8B0015
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Immunotherapy in acute myeloid leukemia.
@en
type
label
Immunotherapy in acute myeloid leukemia.
@en
prefLabel
Immunotherapy in acute myeloid leukemia.
@en
P2093
P2860
P356
P1433
P1476
Immunotherapy in acute myeloid leukemia.
@en
P2093
Dolores A Grosso
Mark A Weiss
Rosemary C Hess
P2860
P304
P356
10.1002/CNCR.29378
P407
P577
2015-06-10T00:00:00Z